Top

Published in:

Open Access 01-12-2024 | Direct Oral Anticoagulant | Research

European expert consensus recommendations on the primary care use of direct oral anticoagulants in patients with venous thromboembolism

Authors: Carter Patrice, Fuat Ahmet, Haas Sylvia, Smyth Elizabeth, Brotons Carlos, Cools Frank, Bauersachs Rupert, Hobbs F. D. Richard

Published in: BMC Primary Care | Issue 1/2024

Abstract

Background

Direct oral anticoagulants for the treatment of venous thromboembolism are supported by robust clinical trial evidence. Despite published guidance, general practitioners are faced with increasingly complex decisions and implementation remains sub-optimal in certain real-world scenarios.

Methods

A two stage formal consensus exercise was performed to formulate consensus statements and a summary guide, facilitating optimal management of direct oral anticoagulants in venous thromboembolism patients by generalist physicians across Europe. An online questionnaire distributed to a broad panel (Phase 1), followed by a virtual panel discussion by an expert group (Phase 2) were conducted. Phase 1 statements covered nine management domains, and were developed via a literature review and expert steering committee. Participants rated statements by their level of agreement. Phase 1 responses were collated and analysed prior to discussion and iterative refinement in Phase 2.

Results

In total 56 participants from across Europe responded to Phase 1. The majority had experience working as general practitioners. Consensus indicated that direct oral anticoagulants are the treatment of choice for managing patients with venous thromboembolism, at initiation and for extended treatment, with a review at three to six months to re-assess treatment effect and risk profile. Direct oral anticoagulant choice should be based on individual patient factors and include shared treatment choice between clinicians and patients; the only sub-group of patients requiring specific guidance are those with cancer.

Conclusion

Results demonstrate an appreciation of best practices, but highlight challenges in clinical practice. The patient pathway and consensus recommendations provided, aim to highlight key considerations for general practice decision making, and aid optimal venous thromboembolism treatment.

Available only for authorised users

Khan F, Tritschler T, Kahn SR, Rodger MA. Venous thromboembolism. Lancet. 2021;398(10294):64–77. https://doi.org/10.1016/s0140-6736(20)32658-1. [published Online First: 2021/05/14].CrossRefPubMed

Nicholson M, Chan N, Bhagirath V, Ginsberg J. Prevention of venous thromboembolism in 2020 and Beyond. J Clin Med. 2020;9(8):2467. https://doi.org/10.3390/jcm9082467.CrossRefPubMedPubMedCentral

McNeill S, Bagot CN. Prevention and treatment of venous thromboembolic disease. Prescriber 2018;29.

Roberti R, Iannone LF, Palleria C, et al. Direct oral anticoagulants: from randomized clinical trials to real-world clinical practice. Front Pharmacol. 2021;12:684638. https://doi.org/10.3389/fphar.2021.684638. [published Online First: 2021/06/15].CrossRefPubMedPubMedCentral

Scottish Intercollegiate Guidelines Network (SIGN). Prevention and management of venous thromboembolism. A national clinical guideline Edinburgh [publication number 122]2010 [updated 2014. Available from: https://www.sign.ac.uk/our-guidelines/prevention-and-management-of-venous-thromboembolism/.

Burnett AE, Mahan CE, Vazquez SR, et al. Guidance for the practical management of the direct oral anticoagulants (DOACs) in VTE treatment. J Thromb Thrombolysis. 2016;41(1):206–32. https://doi.org/10.1007/s11239-015-1310-7.CrossRefPubMedPubMedCentral

National Institute for Health and Care Excellence. Venous thromboembolic diseases: diagnosis, managment and thrombophilia testing [NG158] 2020 [Available from: https://www.nice.org.uk/guidance/NG158 accessed April 2022.

Stevens SM, Woller SC, Kreuziger LB, et al. Antithrombotic therapy for VTE Disease: second update of the CHEST Guideline and Expert Panel Report. Chest. 2021;160(6):e545–e608. https://doi.org/10.1016/j.chest.2021.07.055.CrossRefPubMed

Konstantinides SV, Meyer G, Becattini C, et al. 2019 ESC guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS): the Task Force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC). Eur Heart J. 2019;41(4):543–603. https://doi.org/10.1093/eurheartj/ehz405.CrossRef

10.

Ortel TL, Neumann I, Ageno W, et al. American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism. Blood Adv. 2020;4(19):4693–738. https://doi.org/10.1182/bloodadvances.2020001830.CrossRefPubMedPubMedCentral

11.

Luke SH, Rodney JH. NICE guideline: management of venous thromboembolic diseases and role of thrombophilia testing. Thorax. 2013;68(4):391. https://doi.org/10.1136/thoraxjnl-2012-202376.CrossRef

12.

Chapman NH, Lazar SP, Fry M, et al. Clinicians adopting evidence based guidelines: a case study with thromboprophylaxis. BMC Health Serv Res. 2011;11:240. https://doi.org/10.1186/1472-6963-11-240. [published Online First: 20110928].CrossRefPubMedPubMedCentral

13.

Nair R, Aggarwal R, Khanna D. Methods of formal Consensus in Classification/Diagnostic criteria and Guideline Development. Semin Arthritis Rheum. 2011;41(2):95–105. https://doi.org/10.1016/j.semarthrit.2010.12.001.CrossRefPubMedPubMedCentral

14.

Martin K, Beyer-Westendorf J, Davidson BL, et al. Use of the direct oral anticoagulants in obese patients: guidance from the SSC of the ISTH. J Thromb Haemost. 2016;14(6):1308–13. https://doi.org/10.1111/jth.13323. [published Online First: 20160427].CrossRefPubMedPubMedCentral

15.

Perino AC, Fan J, Schmitt S, et al. Anticoagulation treatment and outcomes of venous thromboembolism by Weight and Body Mass Index: insights from the Veterans Health Administration. Circulation: Cardiovasc Qual Outcomes. 2021;14(11):e008005. https://doi.org/10.1161/CIRCOUTCOMES.121.008005.CrossRef

16.

Khorana AA, Noble S, Lee AYY, et al. Role of direct oral anticoagulants in the treatment of cancer-associated venous thromboembolism: guidance from the SSC of the ISTH. J Thromb Haemost. 2018;16(9):1891–94. https://doi.org/10.1111/jth.14219.CrossRefPubMed

17.

Kirschner M, do Hartmann Ó, Parmentier N. Primary Thromboprophylaxis in patients with malignancies: daily practice recommendations by the Hemostasis Working Party of the German Society of Hematology and Medical Oncology (DGHO), the Society of Thrombosis and Hemostasis Research (GTH), and the Austrian Society of Hematology and Oncology (ÖGHO). Cancers (Basel). 2021;13(12). https://doi.org/10.3390/cancers13122905. [published Online First: 2021/07/03].

18.

Key NS, Khorana AA, Kuderer NM, et al. Venous thromboembolism prophylaxis and treatment in patients with Cancer: ASCO Guideline Update. J Clin Oncol. 2023;41(16):3063–71. https://doi.org/10.1200/jco.23.00294.CrossRefPubMed

19.

Annals of Oncology 2023;34(5):452 – 67. doi: 10.1016/j.annonc.2022.12.014.

20.

NHS Health Research Authority. Is my study Research? 2020 [Available from: http://www.hra-decisiontools.org.uk/research/ accessed June 2021.

21.

NHS Health Research Authority. Does my project require review by a Research Ethics Committee? Version 2.0 2020 [Available from: http://www.hra-decisiontools.org.uk/ethics/docs/Algorithm%20-%20Does%20my%20project%20require%20REC%20review%20v2.0%2020200304.pdf accessed June 2021.

Title: European expert consensus recommendations on the primary care use of direct oral anticoagulants in patients with venous thromboembolism
Authors: Carter Patrice
Fuat Ahmet
Haas Sylvia
Smyth Elizabeth
Brotons Carlos
Cools Frank
Bauersachs Rupert
Hobbs F. D. Richard
Publication date: 01-12-2024
Publisher: BioMed Central
Keywords: Direct Oral Anticoagulant
Direct Oral Anticoagulant
Published in: BMC Primary Care / Issue 1/2024
Electronic ISSN: 2731-4553
DOI: https://doi.org/10.1186/s12875-024-02314-7

At a glance: The STEP trials

Springer Medicine

European expert consensus recommendations on the primary care use of direct oral anticoagulants in patients with venous thromboembolism

Abstract

Background

Methods

Results

Conclusion

At a glance: The STEP trials

Springer Medicine

Abstract

Background

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2024

Prevalence of depression, anxiety, and stress and associated reasons among Iranian primary healthcare workers: a mixed method study

Dental practitioners’ knowledge, management practices, and attitudes toward collaboration in the treatment of temporomandibular joint disorders: a mixed-methods study

Development and validation of a scale for the assessment of the knowledge-attitude-practice of parents towards children snoring

Correction: Physiotherapists’ barriers and facilitators to the implementation of a behaviour change-informed exercise intervention to promote the adoption of regular exercise practice in patients at risk of recurrence of low back pain: a qualitative study

Research on the control rate of hypertension under family physician-contracted service

Self-initiated lifestyle changes during a fasting-mimicking diet programme in patients with type 2 diabetes: a mixed-methods study